Robert Bindert Huizinga, EVP of Research at Aurinia Pharmaceuticals Inc. (AUPH), sold 5,000 shares at $18.30 ($92K) on 2021-09-07, disclosed to the SEC on 2021-09-08.
Open-market sale of $92k AUPH by EVP of Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AUPH | SELL | 2021-09-22 | $1.6M | — | Filing → |
| AUPH | SELL | 2021-09-14 | $885K | — | Filing → |